Ernexa Therapeutics Statistics
Total Valuation
ERNA has a market cap or net worth of $2.74 million. The enterprise value is -$2.52 million.
| Market Cap | 2.74M |
| Enterprise Value | -2.52M |
Important Dates
The last earnings date was Friday, November 6, 2026, after market close.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ERNA has 1.63 million shares outstanding. The number of shares has increased by 383.69% in one year.
| Current Share Class | 1.63M |
| Shares Outstanding | 1.63M |
| Shares Change (YoY) | +383.69% |
| Shares Change (QoQ) | +31.87% |
| Owned by Insiders (%) | 25.40% |
| Owned by Institutions (%) | 11.55% |
| Float | 1.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.64 |
| P/TBV Ratio | 0.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.57 |
| Quick Ratio | 2.15 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -474.22 |
Financial Efficiency
Return on equity (ROE) is -352.43% and return on invested capital (ROIC) is -182.25%.
| Return on Equity (ROE) | -352.43% |
| Return on Assets (ROA) | -120.56% |
| Return on Invested Capital (ROIC) | -182.25% |
| Return on Capital Employed (ROCE) | -285.17% |
| Weighted Average Cost of Capital (WACC) | 18.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.00M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -102,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.83% in the last 52 weeks. The beta is 2.74, so ERNA's price volatility has been higher than the market average.
| Beta (5Y) | 2.74 |
| 52-Week Price Change | -95.83% |
| 50-Day Moving Average | 2.75 |
| 200-Day Moving Average | 5.94 |
| Relative Strength Index (RSI) | 31.21 |
| Average Volume (20 Days) | 17,029 |
Short Selling Information
The latest short interest is 33,263, so 2.04% of the outstanding shares have been sold short.
| Short Interest | 33,263 |
| Short Previous Month | 19,877 |
| Short % of Shares Out | 2.04% |
| Short % of Float | 2.73% |
| Short Ratio (days to cover) | 0.23 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.80M |
| Pretax Income | -14.06M |
| Net Income | -13.97M |
| EBITDA | -12.76M |
| EBIT | -12.80M |
| Earnings Per Share (EPS) | -$14.93 |
Balance Sheet
The company has $5.58 million in cash and $309,000 in debt, with a net cash position of $5.27 million or $3.23 per share.
| Cash & Cash Equivalents | 5.58M |
| Total Debt | 309,000 |
| Net Cash | 5.27M |
| Net Cash Per Share | $3.23 |
| Equity (Book Value) | 4.35M |
| Book Value Per Share | 2.64 |
| Working Capital | 4.11M |
Cash Flow
In the last 12 months, operating cash flow was -$10.73 million and capital expenditures -$20,000, giving a free cash flow of -$10.75 million.
| Operating Cash Flow | -10.73M |
| Capital Expenditures | -20,000 |
| Depreciation & Amortization | 40,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -10.75M |
| FCF Per Share | -$6.59 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ERNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -383.69% |
| Shareholder Yield | -383.69% |
| Earnings Yield | -888.39% |
| FCF Yield | -392.13% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on May 4, 2026. It was a reverse split with a ratio of 1:25.
| Last Split Date | May 4, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |